Press Releases ALK-Abelló A/S

Equities

ALK B

DK0061802139

Real-time Estimate Cboe Europe Other stock markets 10:51:56 2024-04-29 am EDT			5-day change	1st Jan Change
130.1 ^DKK	+0.08%		+2.27%	+28.85%

Mar. 14	Transcript : ALK-Abelló A/S - Shareholder/Analyst Call
Mar. 04	New entries in MarketScreener's Europe portfolio

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ALK Abelló A/S : Invitation to the presentation of ALK's first quarter results on Friday 3 May 2024	Apr. 24	PU
Invitation to the presentation of ALK’s first quarter results on Friday 3 May 2024	Apr. 24	GL
Grant of share-based long-term incentive instruments to members of the Board of Management and key employees	Apr. 03	GL
ALK Abelló A/S : Save the date for ALK's Capital Markets Day on 4 June 2024	Mar. 26	PU
Save the date for ALK’s Capital Markets Day on 4 June 2024	Mar. 26	GL
Annual General Meeting in ALK-Abelló A/S held on 14 March 2024	Mar. 14	GL
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff	Mar. 05	GL
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff	Mar. 04	GL
Annual General Meeting in ALK-Abelló A/S on 14 March 2024	Feb. 16	GL
Annual General Meeting in ALK-Abelló A/S on 14 March 2024	Feb. 16	AQ
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff	Feb. 12	GL
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff	Feb. 12	GL
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff	Feb. 12	AQ
Annual report 2023: ALK delivers 9% sales growth with profits up 50%	Feb. 08	GL
Annual report 2023: ALK delivers 9% sales growth with profits up 50%	Feb. 08	AQ
ALK’s 2030 CO2 reduction targets have been approved by SBTi	Feb. 05	GL
ALK’s 2030 CO2 reduction targets have been approved by SBTi	Feb. 05	AQ
Release date of annual report 2023 for ALK and webcast	Jan. 31	GL
ALK’s European registration application for house dust mite SLIT-tablet in young children accepted for review	Jan. 25	GL
ALK completes first part of phase 1 trial with peanut SLIT-tablet	Jan. 18	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ALK-Abelló A/S : No allergy on the horizon

March 12, 2024 at 10:20 am EDT